Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1250 participants.
Also called NCT03254446
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,250 participants
- Sponsor
- Registry
-
NCT03254446
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil, India, Philippines
- Registry status
- Unknown status
Technical summary
Registry record NCT03254446. Randomized; quadruple masking; primary purpose treatment. Start 2018-03-12 (actual); primary completion 2022-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension
- Condition
- Diabetes
- Condition
- Dyslipidemias
- Condition
- Hypertension
- Intervention (Drug)
- TRC150094
- Intervention (Drug)
- Placebo
- Lead sponsor
- Torrent Pharmaceuticals Limited
- Collaborator
- IQVIA Pty Ltd
Record details
- Record id
cardio:ct-nct03254446- Content hash
6341b1964456ad75ef73008ab76013f859c776d9accf84d3bc96a581cde685f0